Connection

Mark Hamann to Staphylococcal Infections

Back to Details
This is a "connection" page, showing publications Mark Hamann has written about Staphylococcal Infections.
Mark Hamann
Connection Strength
0.343
Staphylococcal Infections
  1. The anti-MRSA compound 3-O-alpha-L-(2?,3?-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus. J Proteomics. 2020 01 06; 210:103539.
    View in: PubMed
    Score: 0.147
  2. HPLC Plasma Assay of a Novel Anti-MRSA Compound, Kaempferol-3-O-Alpha-L-(2",3"-di-p-coumaroyl)rhamnoside, from Sycamore Leaves. Nat Prod Commun. 2015 Aug; 10(8):1383-6.
    View in: PubMed
    Score: 0.110
  3. Antimicrobial metabolites from the Paracel Islands sponge Agelas mauritiana. J Nat Prod. 2012 Apr 27; 75(4):774-8.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.